Status:
COMPLETED
Initial Clinical Presentation of Inflammatory Optic Neuritis Associated or Not With Autoantibodies Anti-Myelin-oligodendrocyte-glycoprotein
Lead Sponsor:
Nantes University Hospital
Conditions:
Optic Neuritis
Eligibility:
All Genders
18+ years
Brief Summary
In eight ophthalmic units, the investigator will include all inflammatory optic neuritis (ON) during acute phase and rank them in two groups: 1/ ON with autoantibodies anti-myelin-oligodendrocyte-glyc...
Detailed Description
Optic neuritis (ON) have a broad clinical spectrum ranging from a single episode (clinically isolated ON) to demyelinating diseases such as multiple sclerosis (MS), Chronic Relapsing Inflammatory Opti...
Eligibility Criteria
Inclusion
- legally adult patient
- acute inflammatory optic neuritis
- consent
Exclusion
- Patient under tutorship
Key Trial Info
Start Date :
February 12 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 31 2022
Estimated Enrollment :
103 Patients enrolled
Trial Details
Trial ID
NCT03345537
Start Date
February 12 2018
End Date
March 31 2022
Last Update
August 25 2022
Active Locations (8)
Enter a location and click search to find clinical trials sorted by distance.
1
Chu Angers
Angers, France
2
Ch Challans
Challans, France
3
Ch Cholet
Cholet, France
4
Chd La Roche Sur Yon
La Roche-sur-Yon, France